NCT07516353 2026-04-08
my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults
Dana-Farber Cancer Institute
Phase NA Not yet recruiting
Clinical Trials
79 trialsNCT07514819 2026-04-07
Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma
St. Jude Children's Research Hospital
Phase NA Not yet recruiting
NCT07511114 2026-04-06
A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated DEL Under the Guidance of Genotyping
Ruijin Hospital
Phase 3 Not yet recruiting
NCT07507773 2026-04-02
NEORASARC
Centre Oscar Lambret
Phase 2 Not yet recruiting
NCT07505732 2026-04-01
Information-providing Chatbot
The Hong Kong Polytechnic University
Phase NA Not yet recruiting
NCT07502885 2026-03-31
Deep Phenotyping Gait Deficits in Orthopedic Manifestations of Pediatric Cancer Patients
St. Jude Children's Research Hospital
Not yet recruiting
NCT07503054 2026-03-31
AI-OCS-Gyn
Charite University, Berlin, Germany
Phase NA Not yet recruiting
NCT07492823 2026-03-25
Clinical Applicability of Liquid Biopsy in Chondrosarcoma
Medical University of Graz
Not yet recruiting
NCT07491783 2026-03-24
Nano-Carbon Iron Suspension Injection Combined With Radiotherapy for Solid Tumors Phase II Clinical Trial
Sichuan Enray Pharmaceutical Sciences Company
Phase 2 Not yet recruiting
NCT07487870 2026-03-23
Radiographic Evaluation of Tumor Biology During Neoadjuvant Radiotherapy for Sarcoma
University of Cincinnati
Phase NA Not yet recruiting
NCT06898203 2026-03-13
PRIME-KS
Washington University School of Medicine
Phase NA Not yet recruiting
NCT07467772 2026-03-12
Ph 2 Elacestrant in ER Positive Uterine Sarcomas
Dana-Farber Cancer Institute
Phase 2 Not yet recruiting
NCT07460986 2026-03-10
BEXAR
MedSIR
Phase 1/2 Not yet recruiting
NCT07457775 2026-03-09
Liposomal Irinotecan in Combination With Temozolomide and Bevacizumab in Patients With Advanced STS
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 2 Not yet recruiting
NCT07297160 2026-03-04
CALySSEY
Baylor College of Medicine
Phase 1 Not yet recruiting
NCT07444619 2026-03-03
A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab (TraPIN) in Pediatric and Young Adult Patients With Recurrent Soft Tissue Sarcomas
M.D. Anderson Cancer Center
Phase 1 Not yet recruiting
NCT07444918 2026-03-03
Liposomal Irinotecan, Vincristine, Temozolomide, and Anlotinib for R/R Pediatric Solid Tumors
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Not yet recruiting
NCT07443137 2026-03-02
CAR-T ceLL for Eradication of Active Residual Disease in LBCL (CLEAR-1 Study)
Stanford University
Phase 1 Not yet recruiting
NCT07038278 2026-02-27
5-ALARMS
University of Colorado, Denver
Phase EARLY_PHASE1 Not yet recruiting
NCT07434843 2026-02-27
PEMIGIST
Dana-Farber Cancer Institute
Phase 2 Not yet recruiting
NCT07406087 2026-02-25
Navigation Intervention for Adolescent and Young Adult Cancer Survivors
Kaiser Permanente
Phase NA Not yet recruiting
NCT07428993 2026-02-24
Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diagnosed High-Risk Osteosarcoma
St. Jude Children's Research Hospital
Phase 2 Not yet recruiting
NCT07396116 2026-02-12
FUSION-02
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase NA Not yet recruiting
NCT05253131 2026-02-11
Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas
University of Alabama at Birmingham
Phase 2 Not yet recruiting
NCT07401355 2026-02-10
LIGHT-CTC
Centre Leon Berard
Phase NA Not yet recruiting
NCT06712433 2026-02-09
CONCERTO
University of Pittsburgh
Phase 2 Not yet recruiting
NCT07211737 2026-02-06
NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma
Baylor College of Medicine
Phase 1 Not yet recruiting
NCT07389356 2026-02-05
Modified R-MINE Regimen vs. R-GemOx Regimens on the Treatment of Late Relapsed DLBCL
The First Affiliated Hospital with Nanjing Medical University
Phase NA Not yet recruiting
NCT07389525 2026-02-05
Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) Study
Indiana University
Phase EARLY_PHASE1 Not yet recruiting
NCT07355855 2026-01-21
A Clinical Study on the Efficacy and Safety of All-trans Retinoic Acid Combined With VAC Regimen in the Treatment of Intermediate-to-high-risk Rhabdomyosarcoma
Fudan University
Phase 2 Not yet recruiting
NCT07342322 2026-01-15
A Prospective, Multicenter, Open-label, Single-arm Phase II Clinical Study Evaluating the Efficacy and Safety of Spatially Fractionated Radiotherapy Combined With the PraG Strategy for the Treatment of Soft Tissue Sarcoma
First Affiliated Hospital of Guangxi Medical University
Phase 2 Not yet recruiting
NCT07337018 2026-01-13
RERIO
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Not yet recruiting
NCT07321912 2026-01-08
Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma
Milton S. Hershey Medical Center
Phase 2 Not yet recruiting
NCT07326371 2026-01-08
Glofitamab Combined With CAR-T Therapy in R/R DLBCL
Ruijin Hospital
Phase 2 Not yet recruiting
NCT07314424 2026-01-02
The Effect of Preoperative Intravenous Ferric Derisomaltose and EPO and Tranexamic Acid in Patients With Preoperative Anemia or Iron Deficiency in Bone Tumor
Peking University People's Hospital
Phase 4 Not yet recruiting
NCT07054944 2025-12-15
T-LyM
University of Rochester
Phase 1 Not yet recruiting
NCT07273045 2025-12-09
reGISTTry
Universität Duisburg-Essen
Not yet recruiting
NCT07261657 2025-12-03
N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive Cellular Therapy
Northwestern University
Phase EARLY_PHASE1 Not yet recruiting
NCT07027423 2025-12-01
BOLD-100 Plus Doxorubicin in Advanced Soft Tissue Sarcomas
University Health Network, Toronto
Phase 1 Not yet recruiting
NCT07250334 2025-11-26
SARCOMA-01
Yonsei University
Phase NA Not yet recruiting
NCT07231250 2025-11-19
Glofitamab Plus Polatuzumab Vedotin and Zuberitamab in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma
Sun Yat-sen University
Phase 2 Not yet recruiting
NCT07224568 2025-11-04
INTERCEPT
Seattle Children's Hospital
Phase 1 Not yet recruiting
NCT07205185 2025-10-03
A Multicenter, Single-arm, Prospective Phase II Clinical Study of Epalrotokewali Combined With Eribulin, Anlotinib, and Radiotherapy for the Treatment of Patients With Advanced Soft Tissue Sarcoma.
Fudan University
Phase 2 Not yet recruiting
NCT07142863 2025-08-27
Envafolimab Combined With Neoadjuvant Chemotherapy Treat Stage IIb Resectable Osteosarcoma Patients
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2 Not yet recruiting
NCT07109024 2025-08-19
PATHFINDERS
Universität Duisburg-Essen
Not yet recruiting
NCT07106411 2025-08-06
CEH-EUS for Differentiating GISTs and Leiomyomas: A Multicenter Prospective Self-Controlled Study
Huazhong University of Science and Technology
Not yet recruiting
NCT07104682 2025-08-05
CLIC-YYC-GPNMB
University of Calgary
Phase EARLY_PHASE1 Not yet recruiting
NCT06772233 2025-07-31
A Study of Regorafenib Combined With Envafolimab for Metastatic Gastrointestinal Stromal Tumors With Kit Gene Exon 17 Mutation That Failed Standard Treatment
Peking University
Phase 2 Not yet recruiting
NCT07092306 2025-07-29
A Randomized Controlled Study Comparing the Safety and Efficacy of Irinotecan Hydrochloride Liposome Injection Combined With Temozolomide and Vincristine (NALIRI-VT) Versus Irinotecan Combined With Temozolomide and Vincristine (VIT) in Patients With Advanced Ewing's Sarcoma
Peking University People's Hospital
Phase 2 Not yet recruiting
NCT07056946 2025-07-15
Supra Inguinal Fascia Iliaca Block Versus Ultrasound-guided Caudal Analgesia for Pediatrics Undergoing Anterior and Lateral Thigh Surgeries: A Randomized Controlled Trial
National Cancer Institute, Egypt
Phase NA Not yet recruiting